Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacokinetic Models: Comparison and Selection Criterion01:26

Pharmacokinetic Models: Comparison and Selection Criterion

174
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
174
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

148
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
148
Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

436
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
436
Pharmacokinetic Models: Overview01:20

Pharmacokinetic Models: Overview

1.3K
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
1.3K
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches01:14

Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches

252
Drug disposition in the body is a complex process and can be studied using two major approaches: the model and the model-independent approaches.
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
252
Model Approaches for Pharmacokinetic Data: Compartment Models01:14

Model Approaches for Pharmacokinetic Data: Compartment Models

258
Compartmental analysis is a widely adopted approach to characterizing drug pharmacokinetics. It uses compartment models that conceptualize the body as a collection of reversibly communicating compartments, each representing a group of tissues exhibiting similar drug distribution characteristics. The movement rate of the drug between these compartments is typically described by first-order kinetics.
Two primary types of compartment models are recognized: mammillary and catenary. The more...
258

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Drug Development.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2025
Same author

Frequency Coding of Multisensory Integration in the Local Field Potentials of the Medial Pulvinar.

The European journal of neuroscience·2025
Same author

Bardet-Biedl Syndrome: Report of a Classical Case from North India.

Annals of African medicine·2025
Same author

LEVERAGING CONTRAST AGENT KINETICS FOR ROBUST REFLECTANCE MODE FLUORESCENCE TOMOGRAPHY.

Proceedings. IEEE International Symposium on Biomedical Imaging·2025
Same author

Interplay between pharmacokinetics and immunogenicity of therapeutic proteins: stepwise development of a bidirectional joint pharmacokinetics-anti-drug antibodies model.

Journal of pharmacokinetics and pharmacodynamics·2025
Same author

AI-Driven Applications in Clinical Pharmacology and Translational Science: Insights From the ASCPT 2024 AI Preconference.

Clinical and translational science·2025

Related Experiment Video

Updated: Oct 15, 2025

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
12:18

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

7.7K

Population pharmacokinetic model selection assisted by machine learning.

Emeric Sibieude1,2, Akash Khandelwal3, Pascal Girard2

  • 1School of Basic Sciences, EPFL, Lausanne, Switzerland.

Journal of Pharmacokinetics and Pharmacodynamics
|October 28, 2021
PubMed
Summary
This summary is machine-generated.

Supervised machine learning, including genetic algorithms and neural networks, can significantly improve the efficiency of population pharmacokinetic model selection. These methods offer substantial computational gains and accurate model selection, especially for large datasets.

Keywords:
Deep learningGenetic algorithmModel-informed drug discovery and developmentNeural networkPharmacometricsPopulation PK/PD

More Related Videos

Constructing and Visualizing Models using Mime-based Machine-learning Framework
06:19

Constructing and Visualizing Models using Mime-based Machine-learning Framework

Published on: July 22, 2025

1.1K
Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers
03:37

Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers

Published on: March 1, 2024

974

Related Experiment Videos

Last Updated: Oct 15, 2025

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
12:18

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

7.7K
Constructing and Visualizing Models using Mime-based Machine-learning Framework
06:19

Constructing and Visualizing Models using Mime-based Machine-learning Framework

Published on: July 22, 2025

1.1K
Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers
03:37

Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers

Published on: March 1, 2024

974

Area of Science:

  • Pharmacometrics
  • Computational Biology
  • Machine Learning

Background:

  • Population pharmacokinetic (PopPK) model development requires robust structural and statistical models.
  • Model selection is a complex and computationally intensive process in pharmacometrics.

Purpose of the Study:

  • To evaluate the utility of supervised machine learning (ML) algorithms for population pharmacokinetic model selection.
  • To compare the performance of ML methods against classical approaches using simulated data.

Main Methods:

  • Simulated pharmacokinetic data were used to compare classical pharmacometric methods with genetic algorithms (GA) and neural networks (NN).
  • GA performance was evaluated using log-likelihood, while NNs were trained with mean square error or binary cross-entropy loss.
  • NN classification and regression tasks were assessed for accuracy and precision.

Main Results:

  • ML methods provided accurate model selection based on statistical rules.
  • GA successfully identified plausible models through its minimization process.
  • NN classification demonstrated the highest accuracy, outperforming NN regression and GA.
  • Substantial computational time savings were observed with ML, particularly with NNs.

Conclusions:

  • Supervised ML algorithms can enhance the efficiency of population pharmacokinetic model selection.
  • ML methods are particularly beneficial for large datasets or complex models with long run times.
  • ML can facilitate a rapid initial model selection, complementing traditional pharmacometric techniques.